Impact of second-line cetuximab-containing therapy in patients with KRAS wild-type metastatic colorectal cancer: results from the ITACa randomized clinical trial

por Passardi, Alessandro, Scarpi, Emanuela, Gelsomino, Fabio, Palladino, Maria Angela, Casadei Gardini, Andrea, Turci, Daniele, Chiuri, Vincenzo Emanuele, Mucciarini, Claudia, Tassinari, Davide, Ragazzini, Angela, Frassineti, Giovanni Luca, Valgiusti, Martina, Ulivi, Paola, Amadori, Dino
Publicado 2017

Niraparib with Abiraterone Acetate and Prednisone for Metastatic Castration-Resistant Prostate Cancer: Phase II QUEST Study Results

por Chi, Kim N, Fleshner, Neil, Chiuri, Vincenzo Emanuele, Van Bruwaene, Siska, Hafron, Jason, McNeel, Douglas G, De Porre, Peter, Maul, Raymond Scott, Daksh, Mahesh, Zhong, Xiaogang, Mason, Gary E, Tutrone, Ronald F
Publicado 2023

Effects of abiraterone acetate plus prednisone on bone turnover markers in chemotherapy-naïve mCRPC patients after ADT failure: A prospective analysis of the italian real-world stu...

por Santini, Daniele, Cinieri, Saverio, Gasparro, Donatello, Bordonaro, Roberto, Guglielmini, Pamela Francesca, Chiuri, Vincenzo Emanuele, D'Angelillo, Rolando M, Ceresoli, Giovanni Luca, Fagnani, Daniele, Acquati, Mirko, Mencoboni, Manlio, Lanzetta, Gaetano, Sartori, Donata, Carlini, Paolo, Panebianco, Fabiana, Beccaglia, Patrizia, Procopio, Giuseppe
Publicado 2020

Immune Modulation in Prostate Cancer Patients Treated with Androgen Receptor (AR)-Targeted Therapy

por Conteduca, Vincenza, Caffo, Orazio, Scarpi, Emanuela, Sepe, Pierangela, Galli, Luca, Fratino, Lucia, Maines, Francesca, Chiuri, Vincenzo Emanuele, Santoni, Matteo, Zanardi, Elisa, Massari, Francesco, Toma, Ilaria, Lolli, Cristian, Schepisi, Giuseppe, Sbrana, Andrea, Kinspergher, Stefania, Cursano, Maria Concetta, Casadei, Chiara, Modonesi, Caterina, Santini, Daniele, Procopio, Giuseppe, De Giorgi, Ugo
Publicado 2020

Effectiveness of abiraterone acetate plus prednisone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer in a large prospective real-world cohort: t...

por Procopio, Giuseppe, Chiuri, Vincenzo Emanuele, Giordano, Monica, Mantini, Giovanna, Maisano, Roberto, Bordonaro, Roberto, Calvani, Nicola, Facchini, Gaetano, De Placido, Sabino, Airoldi, Mario, Sbrana, Andrea, Gasparro, Donatello, Ludovico, Giuseppe Mario, Guglielmini, Pamela, Naglieri, Emanuele, Fagnani, Daniele, Aglietta, Massimo, Schips, Luigi, Beccaglia, Patrizia, Sciarra, Alessandro, Livi, Lorenzo, Santini, Daniele
Publicado 2020

First-line treatment of metastatic castration-resistant prostate cancer: the real-world Italian cohort of the Prostate Cancer Registry

por Galli, Luca, Chiuri, Vincenzo Emanuele, Di Lorenzo, Giuseppe, Pisconti, Salvatore, Rossetti, Sabrina, Sirotova, Zuzana, Muto, Andrea, Petrioli, Roberto, De Tursi, Michele, Sbrana, Andrea, Francolini, Giulio, Ardizzoia, Antonio, Scavelli, Claudio, Satta, Francesco, Quadrini, Silvia, Airoldi, Mario, D’Aniello, Carmine, Bonetti, Andrea, Conforti, Serafino, Aieta, Michele, Beccaglia, Patrizia, Maestri, Antonio, Fratino, Lucia
Publicado 2022

Predictors of long-term response to abiraterone in patients with metastastic castration-resistant prostate cancer: a retrospective cohort study

por Verzoni, Elena, Giorgi, Ugo De, Derosa, Lisa, Caffo, Orazio, Boccardo, Francesco, Facchini, Gaetano, Porcu, Luca, Vincenzo, Fabio De, Zaniboni, Alberto, Chiuri, Vincenzo Emanuele, Fratino, Lucia, Santini, Daniele, Adamo, Vincenzo, Vivo, Rocco De, Dinota, Angelo, Messina, Caterina, Ricotta, Riccardo, Caserta, Claudia, Scavelli, Claudio, Susi, Marina, Tartarone, Alfredo, Surace, Giuseppe, Mosca, Alessandra, Bruno, Michele, Barni, Sandro, Grassi, Paolo, Procopio, Giuseppe
Publicado 2016